SEMA3B and hepatocellular carcinoma: Promoter hyper-methyletion of sema3B was associated with loss of heterozygosity (LOH) in both cell lines and primary tumors in lung cancer and hepatocellular carcinoma, and there is a statistically significant correlation between the sema3B methylation status and LOH at 3p21.3 [170,171,172].